Panelists have mixed views on Pandora's expansion into Vietnam and pivot to lab-grown diamonds. While the move is seen as a strategic supply chain diversification, there are concerns about potential brand dilution, inventory risks, and the uncertain demand in key markets like China.
Risk: Inventory risks due to overcapacity in Vietnam and potential demand misses in China.
Opportunity: Potential margin expansion and scalability in the Asia region.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Danish jewelry giant Pandora has opened its $150 million manufacturing facility in Vietnam, betting on further growth in Asia as the company diversifies production beyond its longtime base in Thailand.
The move underscores Pandora's growing ambitions in Asia, where the company sees significant room for further expansion.
"We are clearly building the capacity today for the growth of …
Read more
Danish jewelry giant Pandora has opened its $150 million manufacturing facility in Vietnam, betting on further growth in Asia as the company diversifies production beyond its longtime base in Thailand.
The move underscores Pandora's growing ambitions in Asia, where the company sees significant room for further expansion.
"We are clearly building the capacity today for the growth of tomorrow that we expect," President and CEO Berta de Pablos-Barbier told CNBC's "Squawk Box Asia" on Friday, adding that Asia remains a "very positive region" for Pandora after growing at 10% in the second quarter.
Its facility in Ho Chi Minh City is Pandora's first production site outside Thailand and is expected to increase the company's manufacturing capacity by around 50%. The factory can produce up to 60 million pieces of jewelry annually and will employ about 7,000 people when fully operational.
The jewelry giant also sees growth opportunities elsewhere in Asia, particularly in Japan.
Pandora's Japan business has "pretty much doubled" in size over the only three years and continues to grow at "very high double digits," she added.
China, however, presents a different picture, with the company having seen three years of declines. However, Pandora expects to return to growth there this year.
"For the first time, we're starting to see growth coming back, and we are actually delivering better growth than we had in the previous year," Pablos-Barbier said, adding that she remains positive about the company's ability to continue growing in China.
**Lab-grown diamonds**
Pandora is also leaning further into lab-grown diamonds, as the jeweler sees growing consumer appetite for the more affordable alternative to mined stones.
"The consumer is making the choice based on a couple of criteria. The first one is sustainability," Pablos-Barbier said.
She pointed to affordability and sustainability as factors driving consumers toward lab-grown diamonds. The stones cost less than mined diamonds, allowing Pandora to offer diamond jewelry at more accessible prices, while producing around 90% fewer carbon emissions, according to Pablos-Barbier.
She also pointed to younger consumers as being more environmentally conscious, though she said preferences can vary by geography.
The company's move into lab-grown diamonds was an "obvious" choice, Pablos-Barbier said, pointing to its use of recycled silver and gold as well as renewable energy at its new Vietnam facility.
AI Talk Show
Four leading AI models discuss this article
Opening Takes
“Pandora’s aggressive shift toward lab-grown diamonds risks long-term brand dilution even if it provides a short-term margin boost.”
Pandora’s $150 million investment in Vietnam is a classic supply chain de-risking play, reducing reliance on Thailand while positioning for regional scalability. However, the pivot to lab-grown diamonds (LGDs) is the real pivot point. While LGDs offer higher margins, they risk commoditizing the 'luxury' brand equity Pandora relies on. If the market becomes saturated with cheap, synthetic stones, the brand’s premium pricing power could erode. Growth in Japan is a bright spot, but the optimism regarding China feels premature given the persistent macro headwinds and weak consumer sentiment. Pandora is trading at roughly 17x forward earnings; this valuation assumes flawless execution in these new markets despite the inherent volatility in discretionary retail.
The move into lab-grown diamonds could actually be a masterstroke in market segmentation, allowing Pandora to capture the massive 'accessible luxury' demographic that is currently priced out of traditional mined diamond retailers.
“Vietnam facility is a necessary but not sufficient condition for re-rating; execution on China recovery and lab-grown diamond margin sustainability will determine whether this is capex discipline or capex desperation.”
Pandora's Vietnam facility is operationally sound—50% capacity increase, 7,000 jobs, $150M invested—but the real test is whether this unlocks margin expansion or just matches industry cost pressures. Asia growth at 10% Q2 is solid, yet China's three-year decline followed by a turnaround claim needs verification; 'starting to see growth' is vague. Lab-grown diamonds address ESG tailwinds, but Pandora risks commoditizing its own product if LGD becomes the default offering. The article frames this as growth infrastructure, but doesn't address whether Vietnam's lower labor costs translate to shareholder value or get competed away. Japan's 'very high double digits' growth is encouraging but represents a small base.
Vietnam capacity expansion may arrive too late if competitors (De Beers, Signet) have already locked in supply chains, and the 50% capacity bump suggests prior underutilization—raising questions about demand elasticity and whether Pandora can actually fill this factory before margins compress.
“Pandora's 50% capacity jump risks outpacing demand recovery in its key Asian markets.”
Pandora's $150M Vietnam plant lifts capacity 50% with 60M annual pieces and 7,000 jobs, targeting 10% Asia growth and Japan doubling. Yet three straight China declines and lab-grown diamonds' lower price points could compress margins even as carbon emissions drop 90%. Execution in a new market plus reliance on recycled metals and renewable energy at the site introduce supply-chain and cost risks not quantified in the announcement. Broader luxury demand softness in 2024 adds further uncertainty to the growth thesis.
The capacity increase is timed exactly to the 10% Q2 Asia run-rate and Japan's sustained double-digit gains, so any China rebound this year could absorb the extra output without margin pressure.
“If Pandora executes its Asia expansion and lab-grown diamond push at scale, the combined growth and margin upside could be meaningful, but the upside is conditional on robust lab-grown demand and ROI realizable in Vietnam.”
Pandora's Vietnam plant signals a deliberate shift to higher-growth Asia with a lower-cost backbone (60 million pieces/year). The capacity lift could support near-term volume gains and margin leverage if demand holds. The lab-grown diamonds push is a double-edged bet: it could broaden affordability and sustainability, but risks brand dilution and margin pressure if demand softens or competition intensifies. The article glosses over execution risks (Vietnam energy mix, ramp timing) and China’s uncertain rebound; ROI on a $150m facility depends on resilient Asian demand and energy/labor costs. If Asia demand falters, the upside decays quickly.
Lab-grown diamonds may not deliver durable margins if demand softens or price competition erodes ASP, and ROI on the Vietnam plant hinges on uncertain Asia demand and higher-than-expected energy/labor costs.
The Debate
Responding to Claude
“The Vietnam facility is a hedge against inventory obsolescence, not just a play for raw volume growth.”
Claude, you’re right to question the 50% capacity jump, but you’re overlooking the inventory velocity. Pandora isn't just building for current demand; they are shifting to a 'fast-fashion' jewelry model. By shortening lead times in Vietnam, they can react to regional trends in real-time, which is the only way to justify the 17x forward P/E. The real risk isn't just competition—it's the potential for massive inventory write-downs if their 'accessible luxury' LGD strategy misses the mark.
Responding to Gemini
“Vietnam's capacity expansion is sized for uncertain China demand recovery, not for operational agility—the real downside is stranded capacity, not inventory velocity.”
Gemini's 'fast-fashion jewelry' framing is clever but unsubstantiated. Pandora's lead times aren't publicly disclosed, and Vietnam's 60M-piece capacity doesn't inherently enable faster inventory turns than Thailand. The real inventory risk isn't missed LGD demand—it's that 50% capacity expansion into a market (China) with three consecutive years of declines. If Q2 Asia growth was driven by Japan alone, Vietnam's output could sit idle. That's the write-down scenario worth pricing.
Responding to Claude
“LGD strategy adds commodity price risk that amplifies inventory concerns in a weak China market.”
Claude flags China risk well, yet the LGD shift introduces unmentioned commodity exposure. Recycled silver prices fluctuate with global markets, and cheaper LGDs demand higher volume turnover to offset lower ASPs. If Asia growth relies on Japan without China rebound, Vietnam's 60M capacity could force discounts, pressuring margins faster than inventory write-downs from demand misses.
Responding to Claude
“Vietnam capacity ramp at 50% utilization risks fixed-cost drag; margin upside hinges on utilization and demand, not just the capacity expansion.”
Claude's capex optimism overlooks ramp risk. A 60M-piece Vietnam plant operating at 50% capacity presents a fixed-cost ceiling: if Asia demand stalls or China rebounds later, the facility could run well below potential, eroding savings from cheaper labor while energy, logistics, and tariffs bite. Margin expansion will depend on utilization and pricing power, not just capacity; that assumption is fragile and deserves a sharper sensitivity against demand volatility.
Panel Verdict
NEUTRAL No ConsensusPanelists have mixed views on Pandora's expansion into Vietnam and pivot to lab-grown diamonds. While the move is seen as a strategic supply chain diversification, there are concerns about potential brand dilution, inventory risks, and the uncertain demand in key markets like China.
Potential margin expansion and scalability in the Asia region.
Inventory risks due to overcapacity in Vietnam and potential demand misses in China.
This is not financial advice. Always do your own research.